InsiderTrades

Form 4 for TWST Twist Bioscience Corp

Accepted 2024-11-13 00:00:00 ET · period of report 2024-11-11 · accession 0000950170-24-126641 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DT 2024-11-13 2024-11-11 TWST CHESS ROBERT Dir M - OptEx $8.82 +3,600 25.2K +17% +$31.8K
DMT 2024-11-13 2024-11-11 TWST CHESS ROBERT Dir S - Sale+OE $47.26 -3,600 22.9K -14% -$170.1K
DT 2024-11-13 2024-11-11 TWST CHESS ROBERT Dir M - OptEx $0.00 -3,600 3,504 -51% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-11-11 M A 3,600 $8.82 25,241 D — —
2 Common Common Stock 2024-11-11 S D 1,276 $47.76 21,641 D — — (F3) Represents the weighted average sales price per share. The shares sold at prices ranging from $47.50 to $47.97 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
3 Common Common Stock 2024-11-11 S D 2,324 $46.99 22,917 D — — (F2) Represents the weighted average sales price per share. The shares sold at prices ranging from $46.50 to $47.44 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
4 Derivative Stock Option (right to buy) 2024-11-11 M D 3,600 $0.00 3,504 D $8.82 · — to 2027-09-28 3,600 Common Stock (F5) The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date